ETFs TAUNS Laboratories,Inc.

197A

JP3452250008

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange 02:30:00 2026-08-28 EDT			5-day change	1st Jan Change
509.00 ^JPY	+1.19%		+0.79%	-

08-26	TAUNS Laboratories,Inc. Announces Directorate Retirements, Effective September 25, 2026	CI
08-18	Craif Inc. announced that it has received ¥3.4 billion in funding from a group of investors	CI

ETFs positioned on TAUNS Laboratories,Inc.

Name	YTD change	Weight	AuM
WISDOMTREE JAPAN SMALLCAP DIVIDEND FUND - USD	+18.41%	0.07%	399 M€
WISDOMTREE INTERNATIONAL HIGH DIVIDEND FUND - USD	+12.96%	0.02%	657 M€
WISDOMTREE INTERNATIONAL SMALLCAP DIVIDEND FUND - USD	+10.42%	0%	1,076 M€
WISDOMTREE GLOBAL HIGH DIVIDEND FUND - USD	+17.08%	0%	162 M€
WISDOMTREE GLOBAL EX?U.S. QUALITY DIVIDEND GROWTH FUND - USD	+13.01%	-.--%	504 M€

Tauns Laboratories Inc is a Japan-based company engaged in the business of developing, manufacturing and marketing in vitro diagnostic products and research reagents. The Company operates its business in the in vitro diagnostic products business segment. The Companyâ€™s main product is antigen test kit that uses immunochromatography to enable rapid diagnosis at the patient's side without the need for special equipment. The products include ImunoAce Flu, ImunoAce SARSCoV-2 II, ImunoAce SARSCoV-2 Saliva, ImunoAce SARSCoV-2/Flu, ImunoAce Adeno, ImunoAce Strep A Neo, ImunoAce hMPV, ImunoAce Mycopiasma, ImunoAce RSV Neo and ImunoAce Noro.

Employees

218

Sector

Medical Equipment, Supplies & Distribution

More about the company